None listed
Conditions
Interventions
Intervention1: MelaB3 serum + microneedling procedure: Trial participants will apply the product at home twice daily (morning and evening) during the study and undergo three microneedling sessions at
Sponsors
La Roche-Posay Laboratoire Dermatologique
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female participants aged above 18 to 65 years 2. Fitzpatrick skin phototypes III to V 3. Trial participants must present with only one facial pigmentary condition either melasma or PIHP 4. Trial participants in good general and mental health in the opinion of the investigator 5. Trial participants demonstrating understanding of the study procedures restrictions and willingness to participate as evidenced by voluntary written informed consent and having received a signed and dated copy of the consent form
Exclusion criteria
Exclusion criteria: 1.Female trial participants who are pregnant or nursing woman or woman planning to get pregnant during the study (self-perceived) 2.Female trial participant who gave birth less than 3 months prior to Day -14, who is pregnant, breast-feeding or who plans to become pregnant during the study; 3.Male trial participant with beard or facial hair, which would interfere with clinical evaluation or clinical procedure baseline); 4.Trial participant with known allergy to any ingredients of the test products (tested product and sunscreen); 5.Trial participant with any inflammatory dermatosis of the face such as seborrheic dermatitis, rosacea etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate & Compare the efficacy levels between treatment groups by Change from Baseline in participants with melasma & PIH by dermatological and instrumental assessmentsTimepoint: D1,D28, D56, D84 | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate & Compare the efficacy & safety of the serum by participant self-assessment questionnaire and by dermatological evaluation.Timepoint: D1,D28, D56, D84 | — |
Countries
India
Contacts
Public ContactSudhanthiran S
MS Clinical Research Pvt. Ltd
Outcome results
None listed